NCT07434609 2026-02-25Evaluation of T320, an Anti-Tissue Factor Antibody-Drug Conjugate, in Patients With Advanced Solid TumorsNanolattix Biotechnology Co., Ltd.Phase 1 Not yet recruiting150 enrolled